Singaporean Regulator Invites Companies To Join Electronic Labeling Trial
Executive Summary
The Health Sciences Authority is evaluating the reliability and feasibility of disseminating package inserts and patient information leaflets electronically.
You may also be interested in...
EU Steps Up Electronic Product Information Plans; Promises Flexibility
Comments are being invited on draft key principles that will form the basis on which ePI for medicines will be developed and used in the EU.
EMA Probe Finds No Link Between GLP-1s And Suicidal Thoughts & Actions
After reviewing the evidence from non-clinical studies, clinical trials, post-marketing surveillance data and other studies, the European Medicines Agency said there was no need to update the product information for 11 diabetes and weight management drugs.
English Funding For Aquipta Targets AbbVie’s Migraine Drug To 170,000 People
Aquipta is the first oral treatment that NICE has recommended for preventing chronic migraines in the fourth-line setting, and the second oral treatment for episodic migraines in the same setting. The drug has already secured reimbursement in Scotland, Sweden and Israel.